Literature DB >> 1940970

Clinical signs in severe Guillain-Barré syndrome: analysis of 63 patients.

A E de Jager1, H J Sluiter.   

Abstract

Clinical data are presented of 63 artificially ventilated Guillain-Barré patients. About half of them had an antecedent event. In 57% the disease was heralded by sensory symptoms. The mean progressive phase lasted 12 days, the plateau 12 days and the recovery phase 568 days. In all patients one or more cranial nerves were involved, most often leading to facial palsy or difficulties in swallowing. Three-quarters of the patients had sensory signs, proprioceptive more often than superficial. Autonomic disturbances were common, especially hypertension and tachycardia. Twenty-two percent of the patients were severely confused in the first weeks of the disease. Laboratory examination showed atypical lymphocytes in the blood of 37% of patients and disturbed hepatic function tests in 79%. CSF protein level was elevated in all patients, with a mean value of 1.5 g/l.

Entities:  

Mesh:

Year:  1991        PMID: 1940970     DOI: 10.1016/0022-510x(91)90303-o

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

Review 1.  Guillain-Barré syndrome.

Authors:  U Seneviratne
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

2.  Detection of serious bradyarrhythmias in Guillain-Barré syndrome: sensitivity and specificity of the 24-hour heart rate power spectrum.

Authors:  P Flachenecker; K Lem; W Müllges; K Reiners
Journal:  Clin Auton Res       Date:  2000-08       Impact factor: 4.435

3.  Impaired joint mobility in Guillain-Barré syndrome: a primary or a secondary phenomenon?

Authors:  I Soryal; E Sinclair; J Hornby; B Pentland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

4.  Guillain-Barré syndrome in children: subtypes and outcome.

Authors:  Zeynep Selen Karalok; Birce Dilge Taskin; Zeliha Brohi Yanginlar; Esra Gurkas; Alev Guven; Aydan Degerliyurt; Ece Unlu; Gulsen Kose
Journal:  Childs Nerv Syst       Date:  2018-06-14       Impact factor: 1.475

Review 5.  Autonomic dysfunction in the neurological intensive care unit.

Authors:  Max J Hilz; Mao Liu; Sankanika Roy; Ruihao Wang
Journal:  Clin Auton Res       Date:  2018-07-18       Impact factor: 4.435

6.  Assessment of autonomic dysfunction in childhood guillain-barré syndrome.

Authors:  Mahmood Samadi; Babak Kazemi; Sona Golzari Oskoui; Mohammad Barzegar
Journal:  J Cardiovasc Thorac Res       Date:  2013-10-05

7.  Dysautonomia and hyponatraemia as harbingers of Guillain-Barre syndrome.

Authors:  Preet Mukesh Shah; Vijay Waman Dhakre; Ramya Veerasuri; Anand Bhabhor
Journal:  BMJ Case Rep       Date:  2019-04-15

Review 8.  Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?

Authors:  Johannes Brettschneider; Axel Petzold; Sigurd Süssmuth; Hayrettin Tumani
Journal:  J Neurol       Date:  2009-02-16       Impact factor: 4.849

9.  Videofluoroscopic evaluation of patients with Guillain-Barré syndrome.

Authors:  M Y Chen; P D Donofrio; M G Frederick; D J Ott; L A Pikna
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

10.  Determination of pain and response to methylprednisolone in Guillain-Barré syndrome.

Authors:  Liselotte Ruts; Rinske van Koningsveld; Bart C Jacobs; Pieter A van Doorn
Journal:  J Neurol       Date:  2007-04-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.